Cleancube Multi: Guardtech Group’s shipping container facilities helping NHS Aseptic Pharmacies MOVE forward
Suffolk contamination control experts’ award-winning Cleancube Mobile Cleanrooms proving to be perfect solution for Trusts that require facility upgrades
Chris Dunn Coaching goes live
Welcome to the Chris Dunn Coaching website - the home of impact and performance for leaders and aspiring leaders.
Price Bailey welcomes Corporate Finance specialist
Price Bailey appoints Chartered Accountant and Corporate Finance specialist Pat Walters, who joins the firm’s Cambridge team as Strategic Business Development Director.
CBMM inaugurates world’s largest Niobium anode production facility dedicated to producing Echion’s leading XNO® technology
CBMM, the global leader in the production and commercialization of Niobium products, has officially inaugurated the world’s first volume manufacturing facility dedicated to producing Echion Technologies’ proprietary ultra-fast charging XNO® active anode material technology.
The Cambridge Building Society invests in rooftop solar panels to drive sustainability
The Cambridge Building Society has announced the completion of a major solar panel installation at its Head Office in central Cambridge, while work continues on its ambitious sustainable residential project.
Council publishes updated proposals for 21st century civic quarter in Cambridge
Cambridge City Council has published its proposals for the Cambridge’s civic quarter – an area consisting of the Guildhall, Corn Exchange, Market Square and surrounding public spaces in central Cambridge – following a
Cambridge Psychosis Centre offers specialist advice for complex cases
CPFT experts have launched a new service providing specialist advice and guidance with research to help people living with severe mental health conditions schizophrenia and psychosis.
New Google to Microsoft 365 migration product by ShareGate
ShareGate has produced a new tool that should make it easier to undertake Google Workspace to Microsoft 365 migrations.
CN Bio launches PhysioMimix Bioavailability assay kit: Human 18
Unique solution enabling researchers to profile human oral drug bioavailability in vitro, in their own laboratories Expands access to CN Bio’s robust multi-organ Gut/Liver-on-a-chip model to accelerate and de-risk clinical progression of drug candidates
Sphere Fluidics strengthens global commercial teams and establishes direct sales and support channel in North America
Significant expansion of global commercial leadership team led by new CEO, Dale Levitzke, to address global demand for the Cyto-Mine Chroma platformCambridge, UK, 14th November 2024: Sph
Primerdesign launches new animal multiplex assays at London Vet Show
Rapid, accurate detection of six gastrointestinal disease-causing pathogens in cats and dogs.
Keytruda LoE: A seismic shift for oncology?
Immune checkpoint inhibitors (ICIs) have changed the face of oncology treatment since their initial entry in the early 2010s. Driven mostly by the group of PD-1 and PD-L1 molecules, they have resulted in cumulative 2023 global revenues exceeding $45 billion USD.
Purpose-led collaboration in Pharma and HealthTech
Co-authored Samuel Hollis - Novartis
Qkine strengthens its support for the cellular agriculture through provision of high quality food grade growth factors
Qkine writes: We are delighted to announce the provision of a new range of high quality food grade growth factors as part of our commitment to driving innovation in the functional recombinant protein supply chain for emerging sectors.
Double the cheer this Christmas with Red Hen
Double the Cheer at Christmas from 3-10 December! We’re excited to share that The Red Hen Project is part of this year’s Big Give Christmas Challenge, where every donation made through our page on BigGive.org will be matched—doubling your impact on children in need in Cambridge.
AstraZeneca invests $3.5 billion in R&D and manufacturing in the United States
AstraZeneca announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and manufacturing footprint by the end of 2026. This includes $2 billion of new investment creating more than a thousand new, high-skilled jobs contributing to the growth of the US economy.
Appointment of new Vice President of Sales and Marketing at Lucida Medical
We are pleased to announce the appointment of Corina Cucuruzac as Vice President of Sales and Marketing at Lucida Medical, effective immediately. With a distinguished career in the MedTech industry across various fields, Corina brings deep expertise in driving growth, building strong customer relationships, and leading successful commercial strategies.
November 2024 - Monthly House Views - US: Towards a Major Change in Economic Policy
The outcome of the US elections turned out to be a clean sweep for the Republican camp after winning not only the White House but also both chambers of the Congress. This combination will put the new President in a strong position to implement the policies announced during his campaign.
100 guests including local sixth form students attend International Men's Day talks and wellbeing workshop at SBC
We were delighted to welcome over 100 guests to International Men’s Day at Stevenage Bioscience Catalyst.
Raise funds for Cogwheel Counselling at the Cambridge Half Marathon
The TTP Cambridge Half Marathon takes place on Sunday 9th March 2025 and we’re really pleased to again be able to offer places to runners who would like to fundraise for Cogwheel Counselling.
Claire Nicholls joins Salus Wellness Clinics
We are excited to welcome Claire Nicholls to Salus Wellness this month.
Bio-Rad demonstrates leadership position in the oncology market at Association for Molecular Pathology 2024
Strength of ddPCR™ Products, Including IVDR Certification, Strategic Collaborations in Molecular Residual Disease Monitoring, and Large Methylation Assay Library, Support Company’s Oncology Strategy
Parkwalk and Cambridge Enterprise launch tenth University of Cambridge Enterprise Fund
Cambridge, November 2024 - Parkwalk Advisors, in collaboration with Cambridge Enterprise, is proud to announce the launch of the University of Cambridge Enterprise Fund X (UCEF X).
Cambridge Index rises 2.2%
The Cambridge Index advanced 465.12 points or 2.2% to close at 21,908, as five out of the top ten index heavyweights posted weekly gains in their share price.
Babraham Research Campus Ltd appoints Dr Louise Jopling as Chief Scientific & Innovation Officer
Cambridge, UK, 12th November 2024: Babraham Research Campus Ltd, which is responsible for the development and management of Babraham Research Campus is delighted to announce the appointment of Dr Louise Jopling to the newly created role of Chief Scientific & Innovation Officer.